Arunjyoti Bio Ventures Share Price
4.74+0.01 (+0.21%)
-33.71% past 1 Year
Arunjyoti Bio Ventures Limited is currently engaged in trading of Bio pesticides, fertilizers and agri inputs. The company to diversify into FMCG and beverages sector apart from carrying out the
Corporate filings & documents
Announcements
Change of Name of the Company from "Arunjyoti Bio Ventures Limited" to "Pasura Industries Limited"
21 hours agoChange of Name of the Company from "Arunjyoti Bio Ventures Limited" to "Pasura Industries Limited"
21 hours agoScrutinizer Report for 40th Annual General Meeting
3 weeks agoScrutinizer Report for 40th Annual General Meeting
3 weeks agoOutcome & Proceedings of 40th Annual General Meeting
3 weeks agoOutcome & Proceedings of 40th Annual General Meeting
3 weeks agoAnnual Report for FY 2025-26 of the Company.
1 month agoAnnual Report for FY 2025-26 of the Company.
1 month agoNotice of AGM for the FY 2025-26 scheduled to be held on 12.08.2026
1 month agoNotice of AGM for the FY 2025-26 scheduled to be held on 12.08.2026
1 month agoChanges in Management
1 month agoChanges in Management
1 month agoUn-Audited Financial Results along with Limited Review Report for the Quarter Ended 30.06.2026.
1 month agoUn-Audited Financial Results along with Limited Review Report for the Quarter Ended 30.06.2026.
1 month agoCertificate under Reg 74(5) of SEBI(DP) Regulations 2018.
1 month agoCertificate under Reg 74(5) of SEBI(DP) Regulations 2018.
1 month agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2026 inter alia to consider and approve 1. Un-audited Financial Results along with Limited Review Report for the Quarter ended 30.06.2026.2. Any other business with the permission of the chair.
2 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2026 inter alia to consider and approve 1. Un-audited Financial Results along with Limited Review Report for the Quarter ended 30.06.2026.2. Any other business with the permission of the chair.
2 months agoClosure of Trading Window for Un-audited Financial Results for the Quarter ending 30.06.2026.
2 months agoClosure of Trading Window for Un-audited Financial Results for the Quarter ending 30.06.2026.
2 months agoAnnual Secretarial Compliance Report for the FY ended 31.03.2026
3 months agoNewspaper Publication for the Audited Financial Results for the Quarter and year ended 31.03.2026
3 months agoAudited Financial Statements for the Quarter and Year ended 31.03.2026
3 months agoAudited Financial Statements for the Quarter and Year ended 31.03.2026
3 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve Audited Financial Results for the Quarter and Year ended 31.03.2026
3 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve Audited Financial Results for the Quarter and Year ended 31.03.2026
3 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve Audited Financial Results for the Quarter and Year ended 31.03.2026.
4 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve Audited Financial Results for the Quarter and Year ended 31.03.2026.
4 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 inter alia to consider and approve Audited Financials results for the Quarter and Year ended 31.03.2026.
4 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 inter alia to consider and approve Audited Financials results for the Quarter and Year ended 31.03.2026.
4 months ago<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Arunjyoti Bio Ventures Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L01400TG1986PLC062463</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2025-26 2026-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Swati Jain</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Vishal Nadimpalli</td></tr> <tr><td>Designation : -</td><td>CFO</td></tr></table><div> <br/> Date: 30/04/2026<br/><br/></div>
4 months ago<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Arunjyoti Bio Ventures Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L01400TG1986PLC062463</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2025-26 2026-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Swati Jain</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Vishal Nadimpalli</td></tr> <tr><td>Designation : -</td><td>CFO</td></tr></table><div> <br/> Date: 30/04/2026<br/><br/></div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Arunjyoti Bio Ventures Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L01400TG1986PLC062463</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>20.57</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Swati Jain <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Vishal Nadimpalli <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Arunjyoti Bio Ventures Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L01400TG1986PLC062463</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>20.57</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Swati Jain <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Vishal Nadimpalli <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Chennupati Sarath Kumar
4 months agoClarification in trading of the shares of the Company.
4 months agoClarification in trading of the shares of the Company.
4 months agoCompliance Certificate under SEBI (DP) Regulations 2018
4 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Chennupati Sarath Kumar
4 months agoClosure of Trading Window
5 months agoClosure of Trading Window
5 months agoIntimation of Installation and commisioning of New Jelly Pouch Production Line
5 months agoUnauited Financial Results along with Limited Review Report for the quarter ended 31.12.2025
7 months agoApproval of Un-audited financial results along with the Limited Review Report for the quarter ended 31.12.2025
7 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve Un-audited financial results along with Limited Review Report for the quarter ended 31.12.2025 and any other business with the permission of the Chair.
7 months agoCompliance Certificate
7 months agoClosure of trading window
8 months agoOutcome
10 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 inter alia to consider and approve Un-audited Financial Results for the quarter ended 30.09.2025
10 months agoCertificate u/r. 75(5)
10 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2025-01-17
Split
10:1
2024-03-12
Rights
8:1;20.0 (Rights ratio;Offer price)
Company details
Registered office
Door No.1-98/1/ J S I C/6 F/604- B 6th Floor Jain Sadhguru Capital Park, Beside Image Gardens Madhapur Hyderabad Telangana PIN: 500081 Tel No: NULL Fax No: NULL Email: [email protected] Internet: www.arunjyoti.com
Registrars
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57, 4th & 5th Floors, Jayabheri Enclave Phase - II, Gachibowli(Old Address:12-10-167, MIG- 167,Bharat Nagar Colony, Hyderabad – 500018.)Phone: +91-40-23818475/6Fax : +91-40-23868024Email: info@vccili Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57 4th & 5th Floors Jayabheri Enclave Phase - II, Gachibowli PIN: Tel No: 23818475,23868257,35164910 Fax No: NULL Email: [email protected] Internet: www.vccipl.com
Management
Dathvik Pabbathi, Whole Time Director
Nadimpalli Vishal, Whole Time Director & CFO
Dhanalakshmi Guntaka, Non Executive Independent Director
Srikar Ranga, Non Executive Independent Director
Vijaya Rama Lakshamana Murthy Mylavarapu, Non Executive Independent Director
Badari Narayana Murthy Pabbathi, Whole Time Director
Swati Jain, Company Secretary & Compliance Officer
Details
BSE 530881
NSE NULL
ISIN INE485K01022